Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,319 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial.
Orenstein R, Dubberke ER, Khanna S, Lee CH, Yoho D, Johnson S, Hecht G, DuPont HL, Gerding DN, Blount KF, Mische S, Harvey A. Orenstein R, et al. Among authors: harvey a. BMC Infect Dis. 2022 Mar 12;22(1):245. doi: 10.1186/s12879-022-07256-y. BMC Infect Dis. 2022. PMID: 35279084 Free PMC article. Clinical Trial.
Retrospective Analysis of the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTATM) Administered Under Enforcement Discretion to Patients With Clostridioides difficile Infection.
Feuerstadt P, Harvey A, Yoho DS, Garcia-Diaz JB, Knapple WL, Bancke L. Feuerstadt P, et al. Among authors: harvey a. Open Forum Infect Dis. 2023 Mar 31;10(5):ofad171. doi: 10.1093/ofid/ofad171. eCollection 2023 May. Open Forum Infect Dis. 2023. PMID: 37256213 Free PMC article.
Safety of fecal microbiota, live-jslm (REBYOTA™) in individuals with recurrent Clostridioides difficile infection: data from five prospective clinical trials.
Lee C, Louie T, Bancke L, Guthmueller B, Harvey A, Feuerstadt P, Khanna S, Orenstein R, Dubberke ER. Lee C, et al. Among authors: harvey a. Therap Adv Gastroenterol. 2023 Jun 12;16:17562848231174277. doi: 10.1177/17562848231174277. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37333464 Free PMC article.
Effect of Fecal Microbiota, Live-Jslm (REBYOTA [RBL]) on Health-Related Quality of Life in Patients With Recurrent Clostridioides difficile Infection: Results From the PUNCH CD3 Clinical Trial.
Garey KW, Dubberke ER, Guo A, Harvey A, Yang M, García-Horton V, Fillbrunn M, Wang H, Tillotson GS, Bancke LL, Feuerstadt P. Garey KW, et al. Among authors: harvey a. Open Forum Infect Dis. 2023 Jul 20;10(8):ofad383. doi: 10.1093/ofid/ofad383. eCollection 2023 Aug. Open Forum Infect Dis. 2023. PMID: 37564743 Free PMC article.
Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides difficile Infection.
Feuerstadt P, Allegretti JR, Dubberke ER, Guo A, Harvey A, Yang M, Garcia-Horton V, Fillbrunn M, Tillotson G, Bancke LL, LaPlante K, Garey KW, Khanna S. Feuerstadt P, et al. Among authors: harvey a. Infect Dis Ther. 2024 Jan;13(1):221-236. doi: 10.1007/s40121-023-00907-w. Epub 2024 Jan 18. Infect Dis Ther. 2024. PMID: 38236515 Free PMC article.
The spectrum of Ih ice using terahertz time-domain spectroscopy.
Tao YH, Dai X, Moggach SA, Clode PL, Fitzgerald AJ, Hodgetts SI, Harvey AR, Wallace VP. Tao YH, et al. Among authors: harvey ar. J Chem Phys. 2024 Jun 7;160(21):214503. doi: 10.1063/5.0193458. J Chem Phys. 2024. PMID: 38828818
Comprehensive care programmes for children with medical complexity.
Harvey AR, Meehan E, Merrick N, D'Aprano AL, Cox GR, Williams K, Gibb SM, Mountford NJ, Connell TG, Cohen E. Harvey AR, et al. Cochrane Database Syst Rev. 2024 May 30;5(5):CD013329. doi: 10.1002/14651858.CD013329.pub2. Cochrane Database Syst Rev. 2024. PMID: 38813833 Review.
2,319 results